Skip to content

US · PACS · MEDICAL - CARE FACILITIES

PACS Group, Inc. (PACS) intrinsic value and stock valuation

$43.67as of 2026-11-21 · Mkt cap 7.22B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

PACS Group, Inc. DCF and intrinsic value

InvestorsCraft values PACS with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from PACS’s statements →

PACS Group, Inc. Graham Number

Graham Number: $12.97d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Salt Lake City, UT 84101 pacs.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$5.29B
20212025
Net income
$191.5M
20212025
Free cash flow
$298.8M
20212025
Total equity
$952.5M
20222025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$5.29B$4.09B$3.11B$2.42B$1.17B
Operating income$309.6M$123.1M$207.8M$229.4M$83.4M
Net income$191.5M$55.8M$112.9M$150.5M$48M
EPSd$1.22M$375.3K$751.7K$1M$319.3K
Operating cash flow$404.2M$367.3M$63.7M$92.6M$57.6M
Capital expenditure-$-105.41M-$-66.47M-$-45.78M-$-22.86M-$-124.09M
Free cash flow$298.8M$300.9M$17.9M$69.8M-$-66.48M
Total assets$5.58B$5.24B$3.51B$2.46B—
Total debt$3.47B$3.5B$2.8B$1.93B—
Net debt$3.27B$3.34B$2.73B$1.87B—
Total equity$952.5M$715.7M$101.7M$68.7M—
Cash and short-term investments$197M$157.7M$73.4M$58.3M—
Income statement
20252024202320222021
Revenue$5.29B$4.09B$3.11B$2.42B$1.17B
Cost of revenue$4.13B$3.3B$2.66B$2.02B$979.2M
Gross profit$1.16B$792.6M$447.1M$400.7M$187.4M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$415.1M$343.8M$213.7M$149M$96.8M
Other expenses$434.6M$325.8M$25.6M$22.3M$7.15M
Operating expenses$849.6M$669.6M$239.3M$171.3M$104M
Cost and expenses$4.98B$3.97B$2.9B$2.19B$1.08B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$28.4M$44.3M$49.9M$25.5M$5.28M
Depreciation and amortization$55.7M$40.8M$25.6M$22.3M$7.15M
Ebitda$365.6M$186.7M$232.9M$254.9M$93.9M
Operating income$309.6M$123.1M$207.8M$229.4M$83.4M
Total other income/expenses, net-$-25.14M-$-21.52M-$-50.45M-$-22.32M-$-1.93M
Income before tax$284.5M$101.6M$157.3M$207M$81.4M
Income tax expense$93M$46.2M$44.4M$56.6M$33.5M
Net income$191.5M$55.8M$112.9M$150.5M$48M
Weighted average shares outstanding$156.2M$146.7M$150.2M$150.2M$150.2M
Weighted average diluted shares outstanding$156.7M$148.6M$150.2M$150.2M$150.2M
Balance sheet
2025202420232022
Cash and short-term investments$197M$157.7M$73.4M$58.3M
Net receivables$702.1M$716.5M$600.1M$420.1M
Inventory$0.00$0.00$0.00$0.00
Total current assets$1.07B$938.3M$722.2M$511.2M
Property, plant and equipment, net$4.17B$3.99B$2.59B$1.78B
Goodwill and intangible assets$68.1M$67.1M$65.3M$61.5M
Long-term investments$0.00$0.00$0.00$0.00
Total non-current assets$4.51B$4.3B$2.79B$1.95B
Total assets$5.58B$5.24B$3.51B$2.46B
Accounts payable$192.2M$175.1M$141M$110.6M
Short-term debt$186.5M$314.3M$127.2M$182.4M
Deferred revenue$0.00$0.00$0.00$0.00
Total current liabilities$1B$978.4M$456.9M$483.9M
Long-term debt$3.28B$3.19B$2.68B$1.74B
Deferred revenue, non-current$0.00$0.00$0.00$0.00
Total non-current liabilities$3.63B$3.55B$2.95B$1.91B
Capital lease obligations$3.12B$3.09B$2.07B$1.43B
Total liabilities$4.63B$4.53B$3.41B$2.39B
Common stock$160K$150K$130K$130K
Retained earnings$309.6M$118M$96M$63.5M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00
Total equity$952.5M$715.7M$101.7M$68.7M
Total investments$0.00$0.00$0.00$0.00
Total debt$3.47B$3.5B$2.8B$1.93B
Net debt$3.27B$3.34B$2.73B$1.87B
Cash flow statement
20252024202320222021
Net income$191.5M$55.8M$112.9M$150.5M$48M
Depreciation and amortization$55.7M$40.8M$25.6M$22.3M$7.15M
Stock-based compensation$54.1M$115.5M$0.00$0.00$0.00
Change in working capital$72.7M$158.2M-$-94.66M-$-94.29M-$-4.36M
Accounts receivable$14.4M-$-116.45M-$-179.94M-$-114.62M-$-40.09M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$14.9M$33.4M$33.4M$32.8M$30.8M
Net cash provided by operating activities$404.2M$367.3M$63.7M$92.6M$57.6M
Investments in property, plant and equipment-$-105.41M-$-66.47M-$-45.78M-$-22.86M-$-124.09M
Acquisitions, net-$-143M-$-281.34M-$-127.02M-$-55.37M-$-79.68M
Net cash used for investing activities-$-264.02M-$-442.68M-$-172.79M-$-75.32M-$-218.6M
Common stock issued$0.00$509.4M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00-$-33.72M-$-80.39M-$-60.28M-$-53.8M
Net cash used for financing activities-$-68.99M$117.5M$129.6M$12.4M$182.1M
Net change in cash$71.2M$42.1M$20.5M$29.6M$21.1M
Cash at end of period$232.1M$160.8M$118.7M$98.2M$68.6M
Operating cash flow$404.2M$367.3M$63.7M$92.6M$57.6M
Capital expenditure-$-105.41M-$-66.47M-$-45.78M-$-22.86M-$-124.09M
Free cash flow$298.8M$300.9M$17.9M$69.8M-$-66.48M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About PACS Group, Inc.

        PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select communities. Founded in 2013 by Jason Murray and Mark Hancock, its corporate headquarters are located in Farmington, Utah.

        CEO
        Jason Murray
        Employees
        47.46K
        Beta
        -0.08

        Explore

        Frequently asked questions

        What is the intrinsic value of PACS Group, Inc. (PACS)?

        PACS Group, Inc. (PACS) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is PACS undervalued?

        PACS trades at a price of $43.67 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.